Patents by Inventor Alagramam N. Kumar

Alagramam N. Kumar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating disorders associated with glycosylation defective proteins
    Patent number: 11865103
    Abstract: A method of treating a glycosylation-defective protein associated disease or disorder in a subject, the method includes administering to the subject a therapeutically effective amount of a Sarco/ER ATPase (SERCA) inhibitor.
    Type: Grant
    Filed: September 7, 2021
    Date of Patent: January 9, 2024
    Assignee: CASE WESTERN RESERVE UNIVERSITY
    Inventors: Alagramam N. Kumar, Suhasini Gopal Ramanujam
  • METHODS OF TREATING DISORDERS ASSOCIATED WITH GLYCOSYLATION DEFECTIVE PROTEINS
    Publication number: 20220168269
    Abstract: A method of treating a glycosylation-defective protein associated disease or disorder in a subject, the method includes administering to the subject a therapeutically effective amount of a Sarco/ER ATPase (SERCA) inhibitor.
    Type: Application
    Filed: September 7, 2021
    Publication date: June 2, 2022
    Inventors: Alagramam N. Kumar, Suhasini Gopal Ramanujam
  • Methods of treating disorders associated with glycosylation defective proteins
    Patent number: 11110076
    Abstract: A method of treating a glycosylation-defective protein associated disease or disorder in a subject, the method includes administering to the subject a therapeutically effective amount of a Sarco/ER ATPase (SERCA) inhibitor.
    Type: Grant
    Filed: February 18, 2020
    Date of Patent: September 7, 2021
    Assignee: CASE WESTERN RESERVE UNIVERSITY
    Inventors: Alagramam N. Kumar, Suhasini Gopal Ramanujam
  • METHODS OF TREATING DISORDERS ASSOCIATED WITH GLYCOSYLATION DEFECTIVE PROTEINS
    Publication number: 20200179333
    Abstract: A method of treating a glycosylation-defective protein associated disease or disorder in a subject, the method includes administering to the subject a therapeutically effective amount of a Sarco/ER ATPase (SERCA) inhibitor.
    Type: Application
    Filed: February 18, 2020
    Publication date: June 11, 2020
    Inventors: Alagramam N. Kumar, Suhasini Gopal Ramanujam